Business Wire Wed, 18 May 2011 07:03 AM PDT
Northwest Biotherapeutics (OTCBB:NWBO) announced today that it is partnering with Fraunhofer for production of DCVax®-L for brain cancer, for clinical trials and compassionate use cases in Europe. Fraunhofer is a highly respected leader in many areas of technology, including cell and immune therapies.

Enhanced Online News Tue, 22 Jun 2004 5:50 AM PDT
DURHAM, NC & TOKYO--(BUSINESS WIRE)--June 22, 2004--Merix Bioscience, a company pioneering therapeutic immunotherapy vaccines, and Kirin Brewery's Pharmaceutical Division, which is developing therapeutic products for renal disease, cancer and immunological disorders, today announced the signing of a collaboration agreement for developing therapies using dendritic cells.

News Observer Tue, 22 Jun 2004 1:29 AM PDT
Merix Bioscience in Durham is partnering with a Japanese company to develop and market its
personalized cancer vaccines in a deal that will bring in millions of dollars in additional operating cash. Kirin and Geron Announce Settlement of Lawsuit

StockHouse U.S. Mon, 21 Jun 2004 10:28 PM PDT
MENLO PARK, Calif., Kirin Brewery Co., Ltd. and Geron Corporation (Nasdaq:GERN) announced today that they have amicably resolved the litigation between them.

Bio-IT World Tue, 22 Jun 2004 8:32 AM PDT
(06/22/04) Cellomics has inked a non-exclusive, worldwide patent license agreement for its core High-Content Screening (HCS) patent portfolio with GE Healthcare (the merged entity of Amersham and GE Medical Systems).